Codiak BioSciences, Inc. Financing Cash Flow
Codiak BioSciences, Inc. reported Financing Cash Flow of $20.74 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-03
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $20.10M, a 2568.79% increase year-over-year.
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $59.00K, a 96.94% decline year-over-year.
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $589.00K, a 99.06% decline year-over-year.
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $208.00K, a 99.72% decline year-over-year.
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $65.41M, a 26.98% decline from fiscal 2020.
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $89.58M, a 817.58% increase from fiscal 2019.
- Codiak BioSciences, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $9.76M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | $20.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $20.16M derived: sum of 2 quarters · filed 2022-11-03 | $20.74M 10-Q · filed 2022-11-03 | $20.95M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $648.00K 10-Q · filed 2022-08-04 | $856.00K derived: sum of 3 quarters · filed 2022-08-04 | $1.61M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $589.00K 10-Q · filed 2022-05-05 | $797.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.55M derived: sum of 3 quarters · filed 2022-11-03 | $3.48M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $961.00K derived: sum of 2 quarters · filed 2022-11-03 | $2.89M derived: sum of 3 quarters · filed 2022-11-03 | $65.41M 10-K · filed 2022-03-10 |
| 2021-09-30 | $753.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.68M derived: sum of 2 quarters · filed 2022-11-03 | $65.20M 10-Q · filed 2022-11-03 | $140.81M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $64.45M 10-Q · filed 2022-08-04 | $140.06M derived: sum of 3 quarters · filed 2022-08-04 | $153.93M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $62.52M 10-Q · filed 2022-05-05 | $138.13M derived: sum of 2 quarters · filed 2022-05-05 | $152.00M derived: sum of 3 quarters · filed 2022-05-05 | $152.09M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $75.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $89.48M derived: sum of 2 quarters · filed 2022-03-10 | $89.56M derived: sum of 3 quarters · filed 2022-03-10 | $89.58M 10-K · filed 2022-03-10 |
| 2020-09-30 | $13.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $13.96M derived: sum of 2 quarters · filed 2021-11-04 | $13.97M 10-Q · filed 2021-11-04 | $13.92M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $104.00K 10-Q · filed 2021-08-05 | $46.00K derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | $18.00K 10-Q · filed 2021-05-06 | -$40.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $9.76M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $9.82M 10-Q · filed 2020-11-19 |